178 related articles for article (PubMed ID: 33429366)
1. Lung adenocarcinoma patients have higher risk of SARS-CoV-2 infection.
Chen L; Liu Y; Wu J; Deng C; Tan J; Liu H; Zhong L
Aging (Albany NY); 2021 Jan; 13(2):1620-1632. PubMed ID: 33429366
[TBL] [Abstract][Full Text] [Related]
2. Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on bioinformatics analyses of gene expression profiles.
Uddin MN; Akter R; Li M; Abdelrahman Z
Chem Biol Interact; 2021 Feb; 335():109370. PubMed ID: 33422520
[TBL] [Abstract][Full Text] [Related]
3. In Silico Identification of miRNA-lncRNA Interactions in Male Reproductive Disorder Associated with COVID-19 Infection.
Sabetian S; Castiglioni I; Jahromi BN; Mousavi P; Cava C
Cells; 2021 Jun; 10(6):. PubMed ID: 34204705
[TBL] [Abstract][Full Text] [Related]
4. Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs.
Pierce JB; Simion V; Icli B; Pérez-Cremades D; Cheng HS; Feinberg MW
Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33207533
[TBL] [Abstract][Full Text] [Related]
5. Expression Analyses of MicroRNAs in Hamster Lung Tissues Infected by SARS-CoV-2.
Kim WR; Park EG; Kang KW; Lee SM; Kim B; Kim HS
Mol Cells; 2020 Nov; 43(11):953-963. PubMed ID: 33199671
[TBL] [Abstract][Full Text] [Related]
6. Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analyses.
Samad A; Jafar T; Rafi JH
Genomics; 2020 Nov; 112(6):4912-4923. PubMed ID: 32916258
[TBL] [Abstract][Full Text] [Related]
7. A new insight into sex-specific non-coding RNAs and networks in response to SARS-CoV-2.
Askari N; Hadizadeh M; Rashidifar M
Infect Genet Evol; 2022 Jan; 97():105195. PubMed ID: 34954105
[TBL] [Abstract][Full Text] [Related]
8. Genomic, epigenomic, and immune subtype analysis of CTSL/B and SARS-CoV-2 receptor ACE2 in pan-cancer.
Li H; Xie L; Chen L; Zhang L; Han Y; Yan Z; Guo X
Aging (Albany NY); 2020 Nov; 12(22):22370-22389. PubMed ID: 33231569
[TBL] [Abstract][Full Text] [Related]
9. Repurposing Methotrexate in Dampening SARS-CoV2-S1-Mediated IL6 Expression: Lessons Learnt from Lung Cancer.
Gowda P; Patrick S; Joshi SD; Kumawat RK; Sen E
Inflammation; 2022 Feb; 45(1):172-179. PubMed ID: 34480250
[TBL] [Abstract][Full Text] [Related]
10. Thrombosis-related circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19.
Eyileten C; Wicik Z; Simões SN; Martins-Jr DC; Klos K; Wlodarczyk W; Assinger A; Soldacki D; Chcialowski A; Siller-Matula JM; Postula M
RNA Biol; 2022 Jan; 19(1):963-979. PubMed ID: 35938548
[TBL] [Abstract][Full Text] [Related]
11. High expression of ACE2 in the human lung leads to the release of IL6 by suppressing cellular immunity: IL6 plays a key role in COVID-19.
Bao Z; Wang LJ; He K; Lin X; Yu T; Li J; Gong J; Xiang G
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):527-540. PubMed ID: 33506945
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin B is a potential therapeutic target for coronavirus disease 2019 patients with lung adenocarcinoma.
Ding X; Ye N; Qiu M; Guo H; Li J; Zhou X; Yang M; Xi J; Liang Y; Gong Y; Li J
Chem Biol Interact; 2022 Feb; 353():109796. PubMed ID: 35007526
[TBL] [Abstract][Full Text] [Related]
13. Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2.
Li Y; Xu Q; Ma L; Wu D; Gao J; Chen G; Li H
J Cell Mol Med; 2020 Aug; 24(16):9478-9482. PubMed ID: 32639084
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 receptor ACE2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress.
Wruck W; Adjaye J
Sci Rep; 2020 Dec; 10(1):21415. PubMed ID: 33293627
[TBL] [Abstract][Full Text] [Related]
15. Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route.
de Oliveira AP; Lopes ALF; Pacheco G; de Sá Guimarães Nolêto IR; Nicolau LAD; Medeiros JVR
Med Hypotheses; 2020 Nov; 144():110243. PubMed ID: 33254549
[TBL] [Abstract][Full Text] [Related]
16. Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract.
Galanopoulos M; Doukatas A; Gazouli M
World J Gastroenterol; 2020 Nov; 26(41):6335-6345. PubMed ID: 33244196
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of miR-200c-3p and miR-421-5p levels during immune responses in the admitted and recovered COVID-19 subjects.
Abdolahi S; Hosseini M; Rezaei R; Mohebbi SR; Rostami-Nejad M; Mojarad EN; Mirjalali H; Yadegar A; Asadzadeh Aghdaei H; Zali MR; Baghaei K
Infect Genet Evol; 2022 Mar; 98():105207. PubMed ID: 34999004
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW
Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814
[TBL] [Abstract][Full Text] [Related]
19. FURIN correlated with immune infiltration serves as a potential biomarker in SARS-CoV-2 infection-related lung adenocarcinoma.
Luo L; Li M; Su J; Yao X; Luo H
Clin Exp Med; 2022 Aug; 22(3):371-384. PubMed ID: 34510311
[TBL] [Abstract][Full Text] [Related]
20. Differential microRNA expression in the peripheral blood from human patients with COVID-19.
Li C; Hu X; Li L; Li JH
J Clin Lab Anal; 2020 Oct; 34(10):e23590. PubMed ID: 32960473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
